Literature DB >> 11468191

Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency.

K C Gilmour1, H Fujii, T Cranston, E G Davies, C Kinnon, H B Gaspar.   

Abstract

Development of T and natural killer (NK) cells is critically dependent on cytokine signaling, and defects in cytokine receptor complex subunits have been shown to result in severe combined immunodeficiency (SCID) syndromes in humans and in murine models. An infant boy had typical clinical features of SCID and was found to lack NK cells in his peripheral circulation. Molecular analysis did not reveal abnormalities in his gammac or JAK-3 genes, and he was investigated for defects in the interleukin-15 (IL-15) receptor complex because functional IL-15 signaling is essential for NK cell development. Expression of the IL-2R/IL-15Rbeta chain was significantly reduced in the patient's peripheral blood mononuclear cells (PBMCs) by immunoblot, flow cytometry, and Northern blot analysis. Furthermore, IL-2 stimulation of PBMCs showed only minimal tyrosine phosphorylation of JAK-3. These data demonstrate that defects in IL-2R/1L-15Rbeta expression can lead to a unique NK-deficient SCID immunophenotype. (Blood. 2001;98:877-879)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468191     DOI: 10.1182/blood.v98.3.877

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

2.  Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Authors:  Blanca E Ruiz-Medina; Jeremy A Ross; Robert A Kirken
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

3.  IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo.

Authors:  Nicholas D Huntington; Nuno L Alves; Nicolas Legrand; Annick Lim; Helene Strick-Marchand; Jean-Jacques Mention; Ariane Plet; Kees Weijer; Yannick Jacques; Pablo D Becker; Carlos Guzman; Patrick Soussan; Dina Kremsdorf; Hergen Spits; James P Di Santo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

Review 4.  Insights into NK cell biology from human genetics and disease associations.

Authors:  Stephanie M Wood; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Cell Mol Life Sci       Date:  2011-08-27       Impact factor: 9.261

5.  Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus.

Authors:  Zhan Huang; Binqing Fu; Song Guo Zheng; Xiaomei Li; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  J Immunol       Date:  2011-02-04       Impact factor: 5.422

6.  Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy.

Authors:  Anna Sliz; Kathryn C S Locker; Kristin Lampe; Alzbeta Godarova; David R Plas; Edith M Janssen; Helen Jones; Andrew B Herr; Kasper Hoebe
Journal:  Sci Immunol       Date:  2019-08-02

Review 7.  Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations.

Authors:  Devin M Jones; Kaitlin A Read; Kenneth J Oestreich
Journal:  J Immunol       Date:  2020-10-01       Impact factor: 5.422

Review 8.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

Review 9.  Cytokine polymorphism and its possible impact on cancer.

Authors:  Ping Jin; Monica C Panelli; Francesco M Marincola; Ena Wang
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 10.  JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.

Authors:  Helena Stabile; Gianluca Scarno; Cinzia Fionda; Angela Gismondi; Angela Santoni; Massimo Gadina; Giuseppe Sciumè
Journal:  Immunol Rev       Date:  2018-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.